Scynexis (SCYX): government contracts, filings & geopolitical news
Scynexis (SCYX) and its matched subsidiaries received $18.5M in federal contract obligations in the last 12 months and $18.5M over the last five years, according to USAspending.gov. The Department of Health and Human Services accounted for 100% of the five-year total. Its largest contract with activity in that period is 75A50126C00007 from the Office of Assistant Secretary for Preparedness and Response for advance the development of scy-247, a novel antifungal currently in phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and ic formula, with $18.5M obligated over the life of the award.
Scynexis government contracts
Obligations by agency
| Agency | Last 12 months | Last 5 years | Share of 5 years |
|---|---|---|---|
| Department of Health and Human Services | $18.5M | $18.5M | 100% |
Top contracting offices (5 years): Office of Assistant Secretary for Preparedness and Response $18.5M.
Largest contracts
| Award | Description · recipient | Agency | Obligated (award total) | Start | End |
|---|---|---|---|---|---|
| 75A50126C00007 | Advance the development of scy-247, a novel antifungal currently in phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and ic formula SCYNEXIS INC | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | $18.5M | Sep 15, 2026 | Jul 31, 2032 |
Newest contracts
| Award | Description · recipient | Agency | Obligated (award total) | Start | End |
|---|---|---|---|---|---|
| 75A50126C00007 | Advance the development of scy-247, a novel antifungal currently in phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and ic formula SCYNEXIS INC | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | $18.5M | Sep 15, 2026 | Jul 31, 2032 |
Matched USAspending recipients: SCYNEXIS INC (UEI H6PSJYEW3DT9, parent with subsidiaries).
Contract data: USAspending.gov (federal prime contract obligations, award types A-D, by action date) and the Department of Defense daily contract announcements (awards of $7.5 million or more). Both are public-domain U.S. government data. Company matching uses legal names and parent/child recipient records and is deliberately conservative, so some subsidiaries may be missing. Obligations are not revenue. Not investment advice.
SCYX share price, last 12 months
Close $4.23 on Jun 12, 2026, +449.4% since Oct 24, 2025 (range $0.58 to $5.33, daily closes).
Company facts
- Ticker
- SCYX (NasdaqCM)
- Sector
- Health
- Industry (SEC SIC code)
- Pharmaceutical Preparations (2834)
- Headquarters (USAspending)
- Jersey City, Nj
Industry from the SEC Standard Industrial Classification code on the company's EDGAR filings.
What changed for Scynexis (SCYX)
- 0 news
- 0 SEC filings
- 0 fund / insider trades
Latest SEC filings
None on record yet.
Latest fund & insider buys and sales
None on record yet.
Latest geopolitical & market news
None on record yet.
Peers: Pharmaceutical Preparations
| Company | Ticker | Federal contracts, 12 months |
|---|---|---|
| Eli Lilly and | LLY | – |
| Johnson & Johnson | JNJ | – |
| AbbVie | ABBV | – |
| Merck | MRK | $2.5M |
| Novartis AG | NVS | – |
| AstraZeneca | AZN | – |
| Abbott Laboratories | ABT | $147.5M |
| Novo Nordisk A/S | NVO | – |
| Pfizer | PFE | -$122K |
| Vertex Pharmaceuticals | VRTX | – |
Biggest government contractors in Health: Regeneron Pharmaceuticals ($279.4M), Fresenius Medical Care AG ($236.7M), Emergent BioSolutions ($216.6M), DaVita ($154.5M), Abbott Laboratories ($147.5M), Amgen ($126.0M), Labcorp Holdings ($96.4M), Stryker ($92.5M).
Congressional trades in SCYX
Trades in SCYX that members of Congress have publicly reported, newest filing first.
No congressional trades are stored for this view yet.
All congressional stock trades →
Geopolitical news for SCYX
Everything on SCYX, newest first
No original notes are listed on this page yet.
Frequently asked questions
How much does the U.S. government spend with Scynexis?
USAspending.gov shows $18.5M in federal contract obligations to Scynexis (SCYX) and its matched subsidiaries in the last 12 months and $18.5M over the last five years (as of Oct 28, 2026).
Which agencies award contracts to Scynexis?
Over five years: Department of Health and Human Services $18.5M.
Where does the contract data come from?
USAspending.gov (the official source of U.S. federal spending data) and the Department of Defense's daily contract announcements. Both are public domain and refreshed daily here.
What geopolitical news affects SCYX?
This page lists every Geopolitics Alpha note that names SCYX as exposed to an event, with the reason it is exposed.
Has Congress traded SCYX?
The table above lists trades in SCYX that members of Congress have publicly reported, with a link to each official filing.
Is this investment advice?
No. We show news, exposure and past price moves. Nothing here is a recommendation.